related documents
- Abstract 1140: Genes preserving stem cell state in group 3 medulloblastoma brain tumor initiating cells contribute to therapy evasion and relapse Conferences
- Abstract 1197: Endothelin-1 receptor/β-arrestin1 is an actionable node that regulates YAP/TAZ signaling and chemoresistance in high-grade ovarian cancer Conferences
- Abstract 148: Canonical Wnt activation as a therapeutic strategy in pediatric medulloblastoma Conferences
- Abstract 1763: BiTEs vs CAR-Ts: Preclinical targeting of CD133+ brain tumor initiating cells using immunotherapy-based treatment strategies Conferences
- Abstract 1911: Uncovering novel targets of recurrent glioblastoma using transcriptomic profiling in a patient-derived xenograft model Conferences
- Abstract 2298: Antibiotic use and breast cancer risk: results from the Sister Study Conferences
- Abstract 2556: Expanded ovarian cancer patient NK cells represent a novel, cytotoxic phenotype and reduce autologous tumor in a patient-derived xenograft ovarian cancer model Conferences
- Abstract 3162: Endothelin-1 receptor/beta-arrestin-1 pathway promotes invadopodia and metastatic process by integration with hMENA in human serous ovarian cancer Conferences
- Abstract 350: Che-1/aatf-induced transcriptionally active chromatin promotes cell growth in multiple myeloma Conferences
- Abstract 3639: Therapeutic targeting of tumorigenic EphA2+/EphA3+ brain tumor initiating cells with bi-specific antibody in human glioblastoma Conferences
- Abstract 3758: The efficacy of CD133 BiTEs and CAR-T cells in preclinical model of glioblastoma Conferences
- Abstract 3844: Identification and validation of novel therapeutic targets driving clonal heterogeneity in treatment-refractory GBM Conferences
- Abstract 3870: Clonal evolution of medulloblastoma BTICs in response to therapy Conferences
- Abstract 390: Genome-wide CRISPR screens in brain tumor initiating cells (BTICs) identify potent sensitizers and resistors of conventional chemoradiotherapy Conferences
- Abstract 4239: The effects of long-term storage on commonly-measured serum analyte levels Conferences
- Abstract 4258: Influence of lifestyle factors on adipocyte size in human breast tissue Conferences
- Abstract 44: Characterization and targeting of a temporal micro-metastatic signature in human brain metastases Conferences
- Abstract 570: A glioblastoma translational pipeline: discovery of novel tumor antigens that drive GBM recurrence Conferences
- Abstract 5831: Activated Wnt signaling for the treatment of recurrent medulloblastoma Conferences
- Abstract 768: miR-378a-5p acts as a positive regulator of melanoma progression Conferences
- Abstract CT110: Clinical pharmacology of tisagenlecleucel (CTL019) in patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) Conferences
- Abstract CT122: Randomized assessment of cisplatin dose interval for ototoxicity in the treatment of locally advanced squamous cell carcinoma of the head and neck undergoing curative concurrent chemoradiotherapy (RADIO) Conferences
- Abstract CT131: A randomized (RCT) phase II study of oncolytic reovirus (pelareorep ) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC) Conferences
- Abstract LB-055: Overall survival and safety experience from an expanded access program (EAP) of nivolumab (NIVO) for patients with advanced melanoma (MEL) who progressed after prior ipilimumab (IPI) treatment Conferences
- Contraceptive use and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers: A prospective cohort study. Conferences
- Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study. Conferences
- Functional mapping reveals widespread remodelling and unrecognized pathway dependencies in recurrent glioblastoma Conferences
- HLA-G, SPAG9 and STAT3 signalling: An alliance that promotes early-stage brain metastases Conferences
- In vivo imaging of mitochondrial bioenergetics in lung cancer. Conferences
- Interrogating the pre-metastastic gene signature to block brain metastases Conferences
- KeyVibe-003: Randomized, double-blind, phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1-positive metastatic NSCLC Conferences
- Rurality and neighborhood socioeconomic deprivation associated with patient-reported outcomes andsurvivalin men with prostate cancer in NRG RTOG 0415. Conferences
- Targeting axonal guidance with anti-ROBO1 CAR T cells: A new therapeutic strategy for malignant brain cancer Conferences
- Understanding small cell lung cancer metastasis using circulating tumor cell (CTC)-derived tumor explant (CDX) models. Conferences